Panel Discussion: Utilizing RNA-Seq for Better Pre-Clinical Predictions & Patient Identification

Time: 11:15 am
day: Preclinical Track - Day 1 am


  • Screening for actionable targets based on targeted RNA-sequencing to make a more accurate prediction of drug efficacy
  • How to preserve the complexity of tumor biology in models?
  • Can we use RNAseq to understand MoA?
  • Can we use baseline RNAseq readouts as patients selection? Is this practical with a gene signature, or do we need to limit this to 1-2 genes to make this practical in clinical trials?